Írsko - angličtina - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove pharma australia pty limited - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - oxytetracycline as the dihydrate; flunixin as flunixin meglumine - parenteral liquid/solution/suspension - oxytetracycline as the dihydrate antibiotic active 300.0 mg/ml; flunixin as flunixin meglumine benzene active 20.0 mg/ml - antibiotic & related - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine respiratory disease | organisms sensitive to oxytetracycline | enteric bacterial infection | respiratory infection | shipping fever

Spojené štáty - angličtina - NLM (National Library of Medicine)

norbrook laboratories limited - oxytetracycline (unii: x20i9en955) (oxytetracycline - unii:x20i9en955), flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - oxytetracycline 300 mg in 1 ml - for the treatment of bacterial pneumonia associated with pasteurella spp. and for the control of associated pyrexia in beef and non-lactating dairy cattle. do not use in animals showing hypersensitivity to either flunixin meglumine or oxytetracycline.

Spojené štáty - angličtina - NLM (National Library of Medicine)

huvepharma, inc - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - only for intravenous use in beef and dairy cattle. not for use in dry dairy cows and veal calves. for intravenous and intramuscular use in horses. before using this drug, read package outsert for complete product information. only for intravenous use in beef and dairy cattle. not for use in dry dairy cows and veal calves. for intravenous and intramuscular use in horses. indications    horse: flu-nix™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse.    cattle: flu-nix™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flu-nix™ (flunixin meglumine injection) is also indicated for the control of inflammation in endotoxemia. contraindications    horse: there are no known contraindications t

Spojené štáty - angličtina - NLM (National Library of Medicine)

aspen veterinary resources, ltd - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - indications    horse : vetameg® (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse.    cattle : vetameg® is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg® is also indicated for the control of inflammation in endotoxemia. contraindications    horse : there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine.    cattle : nsaids inhibit production of prostaglandins which

Spojené štáty - angličtina - NLM (National Library of Medicine)

aspen veterinary resources - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - indications horse: vetameg (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: vetameg (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of still birth. do not use vetameg (flunixin meglumine injection)within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected. safety horse: a 3-fold intramuscular dose of 1.5 mg/lb of body weight daily for 10 consecutive days was safe. no changes were observed in hematology, serum chemistry, or urinalysis values. intravenous dosages of 0.5 mg/lb daily for 15 days; 1.5 mg/lb daily for 10 days; and 2.5 mg/lb daily for 5 days produced no changes in blood or urine parameters. no injection site irritation was observed following intramuscular injection of the 0.5 mg/lb recommended dose. some irritation was observed following a 3-fold dose administered intramuscularly. cattle: no flunixin-related changes (adverse reactions) were noted in cattle administered a 1x (2.2 mg/kg; 1.0 mg/lb) dose for 9 days three times the maximum clinical duration. minimal toxicity manifested itself at moderately elevated doses (3x and 5x) when flunixin was administered daily for 9 days, with occasional findings of blood in the feces and/or urine. discontinue use if hematuria or fecal blood are observed.

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove pharma australia pty limited - flunixin meglumine - parenteral liquid/solution/suspension - flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antiprostaglandin | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - flunixin as flunixin meglumine - parenteral liquid/solution/suspension - flunixin as flunixin meglumine benzene active 50.0 mg/ml - analgesic+musculoskeletal - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling